| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |